BMY 14802, a potential antipsychotic drug, increases expression of proneurotensin mRNA in the rat striatum

Beth Levant, Kalpana M. Merchant, Daniel M. Dorsa, Charles B. Nemeroff

Research output: Contribution to journalArticle

16 Scopus citations


Treatment with efficacious antipsychotic drugs, such as haloperidol, increases the concentrations of neurotensin (NT) in the nucleus accumbens and caudate nucleus of the rat. The increases in NT content produced by haloperidol have been shown to be associated with an increse in NT biosynthesis as assessed by the level of expression of proNT mRNA. The potential antipsychotic drug and σ receptor ligand BMY 14802 has been shown to produce increases in the concentration of NT in the nucleus accumbens and caudate that are similar to those produced by haloperidol with respect to the magnitude of the increases and the time course over which they occur. This study evaluated the effects of BMY 14802 on the expression of proNT mRNA and NT concentration in the rat striatum. Three hours after a single injection of BMY 14802 (35 mg/kg, i.p.) expression of proNT mRNA was significantly increased in the nucleus accumbens and caudat. Labeling was most intense in the dorsal caudate. NT concentrations were unaltered at this time point. Eighteen hours after injection, significant increases in NT concentrations in the nucleus accumbens and caudate were detected. At this time, expression of proNT mRNA was substantially reduced compared to 3 h after treatment although labeling of the dorsal and medial caudate was still greater than that observed in controls.

Original languageEnglish (US)
Pages (from-to)279-284
Number of pages6
JournalMolecular Brain Research
Issue number4
StatePublished - Feb 1992



  • Antipsychotic
  • BMY 14802
  • Neurotensin
  • Proneurotensin mRNA
  • Striatum

ASJC Scopus subject areas

  • Molecular Biology
  • Cellular and Molecular Neuroscience

Cite this